Dates & Deadlines
- 5/22/13 - TechStart and Seed Grant Webinar This webinar will focus on the application…
- 5/23/13 - Funding workshop with MTI and The First Come learn about financing options available…
- 5/24/13 - Funding Workshop with MTI and Norway Savings Bank Come learn about financing options available…
- 5/30/13 - Funding Workshop with MTI and Camden National Bank Come learn about financing options available…
- 6/4/13 - TechStart Grant Deadline All applications due by 5pm
TechStart Grants…
- 6/20/13 - 2013 New England Regional SBIR/STTR Summer Session Increase your chances of winning an SBIR/STTR…
- 7/2/13 - TechStart Grant Deadline All applications due by 5pm
TechStart Grants…
- 7/9/13 - Development Loan Deadline All applications due by 5pm.
Development…
- 8/20/13 - Seed Grant Deadline Applications Due by 5 p.m.
MTI Seed Grants of…
Innovators in the News
2/29/12 - Maine's Pondera teams with Deepak Chopra
From Mass High Tech
Maine nutraceutical company Pondera Pharmaceuticals has launched a line of nutraceutical products endorsed by well-known mind-body medicine pundit Dr. Deepak Chopra.
According to a release from Pownal-based Pondera, the new product is called Deepak Chopra Endorphinate, which the company says is designed to “relieve emotional distress, including anxiety, cravings, anger and fatigue.” The stress-reducing supplement will start shipping on March 10, the release noted.
Pondera is founded by a handful of Crains, according to its website. The president and CEO is lawyer William Crain, and the company is based on the work of his uncle, chief scientific officer for the pharmaceutical division Stanley M. Crain, professor of neurosciences at Albert Einstein College of Medicine, who discovered the bimodal nature of opioid receptors. Dr. Steven Crain is COO and chief scientific officer for the nutraceutical division, and Dr. Michael Crain is chief medical officer.
Nutraceuticals may not get the press of traditional pharmaceuticals, but they do attract funding. In Jan. 2011, Prevention Pharmaceuticals Inc. of New Haven, Conn., sold $650,000 of a $2 million securities offering, to build the company and expand the marketing of its first product, an over-the-counter Omega-3 fatty acid nutraceutical called Omax.
MTI News
- 4/30/13 - Maine Technology Institute will present a second round of workshops in their statewide campaign working with Maine community banks to reach and grow Maine technology-based businesses For Immediate Release
April 30, 2013
Contact: Catherine Marin, 2047-203-2071
Building…
- 4/24/13 - Maine Technology Institute to host federal officials representing $2.5 billion of early-stage technology financing for one day of meetings with entrepreneurs FOR IMMEDIATE RELEASE
Contact: Karen West, 207-845-2934…
MTI Blog
- 3/25/13 - Culture Value One of the objectives we have at the Maine Technology Institute is to help sustain a culture of…
- 1/23/13 - Pinecone Valley: Maine's Hidden Asset When folks talk about hubs of innovation and entrepreneurship, the list invariably includes Silicon…